KRRO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

KRROKorro Bio, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

KRROKorro Bio, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KRRO

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−11.37%—

Q2 FY26—▲+5.39%—

May 7 '26±13.7%▼−3.37%×0.25

Q1 FY26±26.2%▲+11.30%×0.43

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedKRRO realized, solidLLY realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

KRROKorro Bio, Inc.

15.08▼−9.29%

Mkt cap$202.2MRevenue$1MQ4 FY25Revenue$6MFY25

LLYELI Lilly & Co

1,345.49▼−1.41%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

KRROKorro Bio, Inc.

LLYELI Lilly & Co

15.08▼−9.29%

Price

1,345.49▼−1.41%

$202.2M

Mkt cap

$1.2T

Q4 FY25$1M

Revenue

$24.4BQ3 FY26

FY25$6M

Revenue

$65.2BFY25

KRRO15.08▼−9.29%vsLLY1,345.49▼−1.41%Regular sessionNov 6 '26